LeBoyer covers the Healthcare sector, focusing on stocks such as MAIA Biotechnology, Inc., Gyre Therapeutics, and Ocugen. According to TipRanks, LeBoyer has an average return of -10.1% and a 27.17 ...

Gyre Therapeutics (GYRE) announced that the National Medical Products Administration, NMPA, of the People’s Republic of China, PRC, has approved its clinical trial application for a potential ...

Use of Non-GAAP Financial Measures by Gyre Therapeutics, Inc. Gyre reports financial results in accordance with accounting principles generally accepted in the United States (“GAAP”).

The stock price didn't jump after Gyre Therapeutics, Inc. (NASDAQ:GYRE) posted decent earnings last week. We did some digging and believe investors may be worried about some underlying factors in ...